The natural polyphenol fisetin in atherosclerosis prevention: a mechanistic review

Wei Yu1,2,3, Yaping Zhao4, Iqra Ilyas4

  • 1School of Materials Science and Engineering, Hefei University of Technology, Hefei, Anhui, 230009, China.

Insights

Fisetin, a natural polyphenol, shows promise in combating atherosclerotic cardiovascular disease (ASCVD). Research indicates its protective effects on blood vessels and cells, suggesting potential as a future therapy for atherosclerosis.

Area of Science:

  • Cardiovascular Research
  • Pharmacology
  • Natural Product Chemistry

Background:

  • Atherosclerotic cardiovascular disease (ASCVD) incidence and mortality are rising globally.
  • Fisetin, a natural polyphenol, has emerged as a compound with potential anti-atherosclerotic properties.

Purpose of the Study:

  • To review the pharmacologic actions of fisetin in experimental atherosclerosis.
  • To evaluate fisetin's protective effects on key cardiovascular cell types.

Main Methods:

  • Literature review of studies on fisetin and experimental atherosclerosis.
  • Analysis of fisetin's effects on endothelial cells, macrophages, vascular smooth muscle cells, and platelets.

Main Results:

  • Fisetin demonstrates significant anti-atherosclerotic effects in experimental models.
  • Fisetin exhibits protective actions on various cardiovascular cell types relevant to atherosclerosis.

Conclusions:

  • Fisetin possesses profound cardiovascular actions with potential for clinical translation.
  • Further large-scale randomized clinical trials are needed to confirm fisetin's safety and efficacy in ASCVD patients.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
652
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
539
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
686
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
521